Key result
Among pregnant women, 74.4% wanted CMV serological screening, and informed choice was more common among those who chose screening versus those who declined.
Why the study?
The study was conducted to assess the choice and attitude of pregnant women regarding CMV serological screening and CMV prevention behaviors in pregnancy.
What are the perspectives of pregnant women on screening and prevention of CMV in pregnancy?
Cross-Sectional (n=234)
No
What are the perspectives of pregnant women on screening and prevention of CMV in pregnancy?
The majority of pregnant women desire CMV serological screening when informed, highlighting the need for tools to support informed decision-making.
Answers are grounded in this paper and cite their sources.
May inform shared decision-making tools for CMV screening in pregnancy; leaves open effects on congenital outcomes.
OBJECTIVE: To assess the choice and attitude of pregnant women regarding CMV serological screening and CMV prevention behaviors in pregnancy. STUDY DESIGN: In this cross-sectional study, pregnant women were recruited in a single center during routine prenatal screening tests at 11-16 weeks. Participants filled out a questionnaire assessing knowledge about congenital CMV (cCMV) infection, risk perception and willingness to have CMV serological screening as well as their attitude toward CMV prevention behaviors. RESULTS: Among 234 pregnant women, 74.4 % (95 % confidence interval: 68.8-80.0 %) wanted CMV serological screening in pregnancy. The factors significantly associated with the desire for screening were perceived risk and perceived severity of cCMV. An informed choice regarding CMV screening (value-consistent, based on good knowledge and deliberated) was performed by 54 % of women who chose the screening and 30 % of women who declined the screening (p = 0.039). The median scores regarding attitudes toward CMV prevention behaviors were 3.7/5 for avoiding sharing behaviors and 4.0/5 for not kissing a child on the lips. CONCLUSION: The majority of pregnant women want to have CMV serological screening once informed about congenital CMV infection. New tools need to be developed to allow for informed choice regarding CMV serological screening in pregnancy.
No takes yet. Share an insight, caveat, or question.
Beaudoin et al. (2021) conducted a cross-sectional in Pregnancy (n=234). CMV serological screening and prevention behaviors was evaluated on Desire for CMV serological screening in pregnancy (95% CI 68.8-80.0). Among pregnant women, 74.4% wanted CMV serological screening, and informed choice was more common among those who chose screening versus those who declined.
Synapse has enriched 10 related papers. Consider them for comparative context: